| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10K | +0.0% |
| R&D Expense | $14.3M | -29.0% |
| SG&A Expense | $18.2M | -5.0% |
| Operating Income | -$40.0M | -1.9% |
| Net Income | -$37.9M | -2.7% |
| EPS (Basic) | -$0.59 | -1.7% |
| EPS (Diluted) | -$0.59 | -1.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.7M | -74.3% |
| Current Assets | $11.1M | -74.7% |
| Total Assets | $11.1M | -75.5% |
| Current Liabilities | $5.8M | -15.5% |
| Total Liabilities | $5.8M | -16.3% |
| Stockholders' Equity | $5.3M | -86.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.1M | +10.8% |
| Capital Expenditures | $10K | -53.4% |
| Investing Cash Flow | $20K | +193.6% |
| Financing Cash Flow | $5K | -100.0% |
| Free Cash Flow | -$31.1M | +10.9% |